Welcome to our dedicated page for Haleon SEC filings (Ticker: HLN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Haleon plc filings document foreign private issuer disclosures for a global consumer health company whose American depositary shares trade under HLN. Form 6-K reports cover current information such as trading statements, ordinary-share repurchases for cancellation, total voting rights and capital, and annual general meeting poll results.
The filing record also includes debt-market disclosures, including listing particulars for the Euro Medium Term Note programme of Haleon UK Capital plc and Haleon Netherlands Capital B.V. guaranteed by Haleon. Governance and capital-structure disclosures address directors' remuneration, board elections, dividend approvals, special resolutions, ordinary shares, treasury shares, voting rights and shareholder notification thresholds.
Haleon plc reported its updated share capital and voting rights position. As at 31 May 2026, the company had 8,859,337,794 ordinary shares of £0.01 each in issue, of which 12,076,964 were held as treasury shares.
This leaves 8,847,260,830 ordinary shares with voting rights. Haleon explains that this voting-rights figure should be used by shareholders and other obliged investors as the denominator when calculating whether they must notify holdings or changes in holdings under the FCA’s Disclosure Guidance and Transparency Rules.
Haleon plc reported the purchase and cancellation of 10,149,493 ordinary shares of £0.01 each under its share buyback programme announced on 12 March 2026. The shares were bought on multiple UK trading venues between 26 and 29 May 2026 at prices generally around the mid‑340 pence range.
After these transactions are settled, Haleon’s registered share capital is 8,859,337,794 ordinary shares, of which 12,076,964 are held as treasury shares. This leaves 8,847,260,830 ordinary shares with voting rights, a figure shareholders can use for regulatory disclosure threshold calculations.
Haleon plc reported that it bought back 2,458,291 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. Purchases between 18 and 22 May 2026 were made across the London Stock Exchange, CBOE (UK) BXE and CXE.
After settlement, Haleon’s registered share capital is 8,869,487,287 ordinary shares, including 12,092,166 held as treasury shares. The number of ordinary shares with voting rights is now 8,857,395,121, a figure shareholders can use for UK disclosure and transparency notifications.
Haleon plc reported routine share acquisitions by two senior executives through dividend reinvestment plans. Chief Financial Officer Dawn Allen acquired 2,596.07411 ordinary shares at £3.4022 per share on 19 May 2026 on the London Stock Exchange. Chief Executive Officer Brian McNamara acquired 24,891.04716 ordinary shares at the same £3.4022 price on the London Stock Exchange and 4,414.93735 American Depositary Shares at $9.2446 each on the New York Stock Exchange, also on 19 May 2026. These transactions reflect automatic reinvestment of cash dividends into additional equity in Haleon.
Haleon plc reported a small share transaction by a senior board member under UK Market Abuse Regulation disclosure rules. Senior Independent Non-Executive Director Alan Stewart acquired 498 ordinary shares of Haleon through a dividend reinvestment on 14 May 2026 at a price of £3.3105 per share on the London Stock Exchange. This is a routine reinvestment of dividends into additional Haleon shares rather than an open-market purchase.
Haleon plc reports that it purchased 8,316,688 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. The purchases took place between 11 and 15 May 2026 across the London Stock Exchange, CBOE UK venues and Aquis.
After settlement, Haleon’s registered share capital is 8,871,945,578 ordinary shares, of which 12,130,560 are held as treasury shares. The number of ordinary shares with voting rights is now 8,859,815,018, a figure shareholders can use for disclosure threshold calculations under UK transparency rules.
Haleon plc reported the repurchase of 10,205,329 ordinary shares of £0.01 each for cancellation under its share buyback programme. The purchases took place between 05 May 2026 and 08 May 2026 across the London Stock Exchange, CBOE (UK) venues and Aquis, at volume weighted average prices around 331–337 pence per share depending on venue and date.
After these transactions settle, Haleon’s registered share capital is 8,880,262,266 ordinary shares, of which 12,184,020 are held as treasury shares. The number of ordinary shares with voting rights is 8,868,078,246, a figure shareholders can use when assessing notification thresholds under the UK Disclosure Guidance and Transparency Rules.
Haleon plc has published updated listing particulars for Haleon UK Capital plc’s and Haleon Netherlands Capital B.V.’s £10,000,000,000 Euro Medium Term Note (EMTN) Programme, which is guaranteed by Haleon. This is described as a routine annual update. The listing particulars, dated 7 May 2026, are available to download from Haleon’s investor debt section online.
The EMTN programme provides a framework under which the group can issue debt securities in the future, subject to applicable terms and investor eligibility set out in the listing particulars.
Haleon plc reported that it purchased 12,171,987 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. The purchases were made between 27 April and 1 May 2026 across the London Stock Exchange, CBOE (UK) venues and Aquis.
After these transactions settle, Haleon’s registered share capital is 8,890,467,595 ordinary shares, of which 12,240,797 are held as treasury shares. The number of ordinary shares with voting rights is 8,878,226,798, which shareholders can use to assess notification thresholds under the FCA’s Disclosure Guidance and Transparency Rules.
Haleon plc reports its share capital and voting rights position as at 30 April 2026. The company has issued a total of 8,891,932,595 ordinary shares of £0.01 each, with 12,240,797 held as treasury shares. As a result, 8,879,691,798 ordinary shares carry voting rights. Shareholders and other parties with notification obligations are instructed to use this voting-rights figure as the denominator when calculating whether they must notify their interest in Haleon under the FCA's Disclosure Guidance and Transparency Rules.